These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9807125)
1. Virulence of six capsular serotypes of Porphyromonas gingivalis in a mouse model. Laine ML; van Winkelhoff AJ Oral Microbiol Immunol; 1998 Oct; 13(5):322-5. PubMed ID: 9807125 [TBL] [Abstract][Full Text] [Related]
2. Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes. Vernal R; León R; Silva A; van Winkelhoff AJ; Garcia-Sanz JA; Sanz M J Clin Periodontol; 2009 Oct; 36(10):823-9. PubMed ID: 19682172 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the capsular polysaccharide biosynthesis locus of Porphyromonas gingivalis and development of a K1-specific polymerase chain reaction-based serotyping assay. Brunner J; Crielaard W; van Winkelhoff AJ J Periodontal Res; 2008 Dec; 43(6):698-705. PubMed ID: 18624945 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens. Sims TJ; Schifferle RE; Ali RW; Skaug N; Page RC Oral Microbiol Immunol; 2001 Aug; 16(4):193-201. PubMed ID: 11442843 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and distribution of six capsular serotypes of Porphyromonas gingivalis in periodontitis patients. Laine ML; Appelmelk BJ; van Winkelhoff AJ J Dent Res; 1997 Dec; 76(12):1840-4. PubMed ID: 9390477 [TBL] [Abstract][Full Text] [Related]
6. The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration. d'Empaire G; Baer MT; Gibson FC Infect Immun; 2006 Nov; 74(11):6236-43. PubMed ID: 16940143 [TBL] [Abstract][Full Text] [Related]
7. Novel polysaccharide capsular serotypes in Porphyromonas gingivalis. Laine ML; Appelmelk BJ; van Winkelhoff AJ J Periodontal Res; 1996 May; 31(4):278-84. PubMed ID: 8814599 [TBL] [Abstract][Full Text] [Related]
8. Effect of host responses on the pathogenicity of strains of Porphyromonas gingivalis. Katz J; Ward DC; Michalek SM Oral Microbiol Immunol; 1996 Oct; 11(5):309-18. PubMed ID: 9028256 [TBL] [Abstract][Full Text] [Related]
9. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Singh A; Wyant T; Anaya-Bergman C; Aduse-Opoku J; Brunner J; Laine ML; Curtis MA; Lewis JP Infect Immun; 2011 Nov; 79(11):4533-42. PubMed ID: 21911459 [TBL] [Abstract][Full Text] [Related]
10. Distinct human T-lymphocyte responses triggered by Porphyromonas gingivalis capsular serotypes. Vernal R; Diaz-Guerra E; Silva A; Sanz M; Garcia-Sanz JA J Clin Periodontol; 2014 Jan; 41(1):19-30. PubMed ID: 24117627 [TBL] [Abstract][Full Text] [Related]
11. K-antigens in Porphyromonas gingivalis are associated with virulence. van Winkelhoff AJ; Appelmelk BJ; Kippuw N; de Graaff J Oral Microbiol Immunol; 1993 Oct; 8(5):259-65. PubMed ID: 8265200 [TBL] [Abstract][Full Text] [Related]
12. Experimental model for Porphyromonas gingivalis infection in animals. Eke PI; Rotimi VO; Laughon BE Afr J Med Med Sci; 1996 Mar; 25(1):31-9. PubMed ID: 9110052 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the capsular polysaccharide (K-antigen) locus of Porphyromonas gingivalis. Aduse-Opoku J; Slaney JM; Hashim A; Gallagher A; Gallagher RP; Rangarajan M; Boutaga K; Laine ML; Van Winkelhoff AJ; Curtis MA Infect Immun; 2006 Jan; 74(1):449-60. PubMed ID: 16369001 [TBL] [Abstract][Full Text] [Related]
14. Adhesion of Porphyromonas gingivalis serotypes to pocket epithelium. Dierickx K; Pauwels M; Laine ML; Van Eldere J; Cassiman JJ; van Winkelhoff AJ; van Steenberghe D; Quirynen M J Periodontol; 2003 Jun; 74(6):844-8. PubMed ID: 12886995 [TBL] [Abstract][Full Text] [Related]
15. The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts. Brunner J; Scheres N; El Idrissi NB; Deng DM; Laine ML; van Winkelhoff AJ; Crielaard W BMC Microbiol; 2010 Jan; 10():5. PubMed ID: 20064245 [TBL] [Abstract][Full Text] [Related]
16. Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis. Califano JV; Schifferle RE; Gunsolley JC; Best AM; Schenkein HA; Tew JG J Periodontol; 1999 Jul; 70(7):730-5. PubMed ID: 10440633 [TBL] [Abstract][Full Text] [Related]
17. The core genome of the anaerobic oral pathogenic bacterium Porphyromonas gingivalis. Brunner J; Wittink FR; Jonker MJ; de Jong M; Breit TM; Laine ML; de Soet JJ; Crielaard W BMC Microbiol; 2010 Sep; 10():252. PubMed ID: 20920246 [TBL] [Abstract][Full Text] [Related]
18. Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant. Yagishita H; Kumagai Y; Konishi K; Takahashi Y; Aoba T; Yoshikawa M Infect Immun; 2001 Nov; 69(11):7159-61. PubMed ID: 11598093 [TBL] [Abstract][Full Text] [Related]
19. Modification of experimental Porphyromonas gingivalis murine infection by immunization with a polysaccharide-protein conjugate. Schifferle RE; Chen PB; Davern LB; Aguirre A; Genco RJ; Levine MJ Oral Microbiol Immunol; 1993 Oct; 8(5):266-71. PubMed ID: 8265201 [TBL] [Abstract][Full Text] [Related]
20. Heterogenic virulence and related factors among clinical isolates of Porphyromonas gingivalis with type II fimbriae. Inaba H; Nakano K; Kato T; Nomura R; Kawai S; Kuboniwa M; Ishihara K; Ooshima T; Amano A Oral Microbiol Immunol; 2008 Feb; 23(1):29-35. PubMed ID: 18173795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]